$MNKD Headlines 7 gut checks before the stock market's

New Post Public Reply Private Reply Replies (0) Message Board
Stock_Tracker
$MNKD Headlines

7 gut checks before the stock market's opening bell 5:25 a.m. Aug. 15, 2013 - Shawn Langlois
On a mixed day, two biopharma firms' insulin drugs vie for investors 10:41 a.m. June 19, 2013 - Russ Britt
MannKind shares leap as web site says firm is a ripe takeover target 12:32 p.m. May 22, 2013 - Russ Britt
MannKind up 6.9% in premarket 7:43 a.m. Jan. 2, 2013 - Steve Gelsi
MannKind prices offering at 23% discount 9:04 a.m. Oct. 18, 2012 - MarketWatch.com
MannKind down 25% in premarket 7:59 a.m. Oct. 18, 2012 - Steve Gelsi
Tuesday’s biggest gaining and declining stocks 4:01 p.m. Sept. 4, 2012 - Greg Morcroft
Hot stocks to watch 6:39 a.m. Sept. 4, 2012 - MarketWatch.com
MannKind in development pact valued up to $130M 6:02 a.m. April 30, 2012 - MarketWatch.com
Stocks to watch Thursday: Diamond Foods, Six Flags 6:59 a.m. Feb. 9, 2012 - MarketWatch
Friday’s biggest gaining & declining stocks 4:48 p.m. Feb. 3, 2012 - Kate Gibson
MannKind prices units offering at 2.8% discount 12:00 p.m. Feb. 3, 2012 - MarketWatch.com
Mannkind sinks 14% on public offering 11:47 a.m. Jan. 31, 2012 - Val Brickates Kennedy
Friday’s biggest gaining & declining stocks 4:28 p.m. Aug. 12, 2011 - Sue Chang
Tuesday’s biggest gaining and declining stocks 3:23 p.m. May 10, 2011 - Kate Gibson
BioMimetic, InterMune drop in afternoon trading 1:59 p.m. May 10, 2011 - Val Brickates Kennedy
Tenet, Community Health fall after hours 6:04 p.m. May 9, 2011 - Carla Mozee
Stocks to watch Tuesday: Disney, McDermott 5:34 p.m. May 9, 2011 - Wallace Witkowski
MannKind awaiting more details from FDA on Afrezza 4:33 p.m. May 9, 2011 - Sue Chang
Depomed slides as drug stocks fall; Mannkind soars 11:36 a.m. Feb. 15, 2011 - Val Brickates Kennedy


A Step Back for MannKind? 11:00 a.m. Today - Barrons.com
MannKind Slips on Afrezza Update - Analyst Blog 1:22 p.m. Jan. 13, 2014 - Zacks.com
The Next Home Run In Healthcare 9:49 a.m. Jan. 13, 2014 - Seeking Alpha
MannKind's Day Of Reckoning Is Getting Very Close 9:33 a.m. Jan. 13, 2014 - Seeking Alpha
Stocks You Wish You Owned on Thursday 10:36 p.m. Jan. 10, 2014 - WallStreetSectorSelector
Afrezza may miss PDUFA date: Cowen, Piper 3:38 p.m. Jan. 10, 2014 - Seeking Alpha
Mid-Afternoon Market Update: Plug Rises on Secondary Pricing as Markets Remain Mixed Following Jobs Number 2:51 p.m. Jan. 10, 2014 - benzinga.com
Volatility and Options in MannKind Shaking Speculators Out 2:06 p.m. Jan. 10, 2014 - 247WallSt.com
How I Think About MannKind's Afrezza FDA Panel 11:37 a.m. Jan. 10, 2014 - TheStreet.com
Mid-Day Market Update: Abercrombie & Fitch Surges On Strong Outlook; Sears Shares Slip 11:27 a.m. Jan. 10, 2014 - benzinga.com
Mid-Morning Market Update: Markets Drop; Alcoa Q4 Earnings Miss Estimates 10:04 a.m. Jan. 10, 2014 - benzinga.com
MannKind Corp. (MNKD) Surges: Stock Moves 18.4% Higher - Tale of the Tape 9:21 a.m. Jan. 10, 2014 - Zacks.com
MannKind announces Ad Com date, shares stumble 9:08 a.m. Jan. 10, 2014 - Seeking Alpha
Stock Watch Friday, 10 January 2013: Mannkind Rallies, Sirius Should Satisfy 8:36 a.m. Jan. 10, 2014 - Seeking Alpha
Scorching Hot Biotech Tape: Small-Cap and Mid-Cap Stocks on Fire 8:33 a.m. Jan. 10, 2014 - 247WallSt.com
Buyout Picks In Healthcare For 2014 7:05 a.m. Jan. 10, 2014 - Seeking Alpha
Biotech Stock Mailbag: NeoStem, MannKind, Inovio 6:00 a.m. Jan. 10, 2014 - TheStreet.com
MannKind Announces Tentative Date of April 1, 2014 for FDA Advisory Committee Review of AFREZZA 5:01 a.m. Jan. 10, 2014 - benzinga.com
2014 Biotechnology Catalysts 4:18 p.m. Jan. 9, 2014 - Seeking Alpha
Cramer's Lightning Round - No Mere Finger Waving At Michael Kors (1/8/14) 6:23 a.m. Jan. 9, 2014 - Seeking Alpha


MannKind Announces Tentative Date of FDA Advisory Committee Review of AFREZZA 6:00 a.m. Jan. 10, 2014 - GlobeNewswire
MannKind Corporation to Present at the J.P. Morgan 2014 Healthcare Conference 5:00 p.m. Jan. 8, 2014 - GlobeNewswire
Clinical Study Updates, Collaborations, and Stock Price Updates - Research Report on Medtronic, Regeneron, Celldex, Cubist, and MannKind 8:00 a.m. Dec. 31, 2013 - PR Newswire
Technical Research on Equities: Ariad Pharma, MannKind, Galena Biopharma, and Novavax 8:00 a.m. Dec. 23, 2013 - PR Newswire
Share Price Movements and Clinical Studies - Research Report on Celldex Therapeutics, Envision, MannKind, Covance, and Auxilium 8:00 a.m. Dec. 19, 2013 - PR Newswire
Stock Price Updates - Research Report on AbbVie, Covance, MannKind, MAKO Surgical, and Envision 8:00 a.m. Dec. 11, 2013 - PR Newswire
Final Hour Buzz: Gilead Sciences, MannKind Corporation, Facebook Inc, Tiger Oil and Energy 2:46 p.m. Dec. 10, 2013 - ACCESSWIRE
Announcements and Sponsorships by Biotechnology Companies and Major Drug Manufacturers - Research Report on Lilly, Geron, MannKind, Techne, and InterMune 8:00 a.m. Dec. 2, 2013 - PR Newswire
MannKind Corporation to Present at The Piper Jaffray 25th Annual Healthcare Conference 5:00 p.m. Nov. 27, 2013 - BusinessWire
Pre-Market Breakdown: Galena Biopharma Inc., Novavax Inc., Ariad Pharma Inc., and MannKind Corp. 8:00 a.m. Nov. 27, 2013 - PR Newswire
Financial Results, Conference Presentations, Stock Price Update, and Warrant Exercises - Research Report on Halozyme Therapeutics, Oxygen Biotherapeutics, ACADIA, MannKind, and ViroPharma 8:00 a.m. Nov. 13, 2013 - PR Newswire
MannKind Corporation to Present at Canaccord Genuity Medical Technologies & Diagnostics Forum 5:00 p.m. Nov. 7, 2013 - BusinessWire
Clinical Trial Data, New Publications, Promotions, Financial Results and FDA Acknowledgements - Research Report on Gilead, Amgen, ACADIA Pharmaceuticals, ViroPharma, and MannKind 8:00 a.m. Nov. 6, 2013 - PR Newswire
MannKind Corporation Reports 2013 Third Quarter Financial Results 9:00 a.m. Nov. 4, 2013 - BusinessWire
Morning Research: Ariad Pharma Inc., MannKind Corp., Novavax Inc., and Galena Biopharma Inc. 12:30 p.m. Nov. 1, 2013 - PR Newswire
MannKind Announces FDA Acknowledgement of Resubmission of New Drug Application for AFREZZA 5:00 a.m. Oct. 30, 2013 - BusinessWire
MannKind Corporation to Hold 2013 Third Quarter Financial Results Conference Call on November 4, 2013 1:12 p.m. Oct. 28, 2013 - BusinessWire
Divestiture, Clinical Study Updates, New Drug Application, and Quarterly Report - Research Report on Geron, NPS, Portola, MannKind, and Exact Sciences 7:00 a.m. Oct. 21, 2013 - PR Newswire
AGNC, ACHN, MNKD and ACAD added to NASDAQ Active Stock Watch List at EPR 8:24 a.m. Oct. 15, 2013 - ACCESSWIRE
MannKind Resubmits New Drug Application to U.S. FDA for AFREZZA for the Treatment of Adults with Diabetes 5:00 a.m. Oct. 14, 2013 - BusinessWire

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Top 5 Most Recently Viewed Articles

Understanding Adobe’s Recent Options Activity Results

Updated Category News Views 114

Adobe's Options Activity Highlights In the world of finance, significant trades often signal important market sentiments. Recently, major investors have moved toward a bearish outlook on Adobe. Analyzing the options history for Adobe (NASDAQ: ADBE), we've identified a total of 67 significant trades. Our insights reveal that approximately 41% of these trades have been...

Continue Reading
Indonesia's Ongoing Challenge with Chinese Maritime Presence

Updated Category News Views 130

Indonesia's Maritime Security Efforts Intensify Recently, Indonesia's maritime security has been under increased scrutiny as incidents involving a Chinese coast guard vessel continue to escalate. This week, a Chinese vessel was driven from Indonesian waters not once, but twice, after interfering with a critical energy survey conducted by Pertamina, the state energy...

Continue Reading
Revolutionizing Game Development with Upheaval Games' Dreamer Portal

Updated Category News Views 140

Welcome to the Future of Game Development Upheaval Games, founded by veterans from the gaming industry, embraces a new frontier in game design with the introduction of The Dreamer Portal. This innovative web-based interface allows creators to effortlessly build immersive game content with just a simple prompt. Imagine the power of crafting unique creatures, items, and...

Continue Reading
Alvotech Moves Forward with Gobivaz® Approval in Europe

Updated Category News Views 190

Alvotech and Advanz Pharma Collaborate for Biosimilar Approval REYKJAVIK and LONDON – Alvotech (NASDAQ: ALVO), a renowned biotechnology firm, along with Advanz Pharma, a leading global pharmaceutical company, has shared important news regarding the marketing approval of Gobivaz®, a proposed biosimilar to Simponi® (golimumab). This biologic treatment is designed for...

Continue Reading
Exploring the Growth Potential of Remote Patient Monitoring Sector

Updated Category News Views 181

Remote Patient Monitoring Set for Dynamic Growth The increasing prevalence of chronic conditions worldwide is expected to significantly accelerate the growth of the remote patient monitoring (RPM) market. As conditions like hypertension, diabetes, and cardiovascular diseases become more common, coupled with an aging population, healthcare systems face immense pressure to...

Continue Reading